Select Medical Holdings Corporation (FRA:S24)
Germany · Delayed Price · Currency is EUR 12.70
-0.90 (-6.62%)
At close: Feb 20, 2026
Select Medical Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 146.22 | 214.04 | 243.49 | 158.99 | 402.23 |
Depreciation & Amortization | 140.3 | 142.87 | 135.69 | 132.16 | 202.65 |
Other Amortization | 3.14 | 2.96 | 2.65 | 2.27 | 2.22 |
Loss (Gain) From Sale of Assets | 0.01 | -1.06 | -0.06 | -2.71 | -2.41 |
Loss (Gain) on Equity Investments | -1.55 | -21.05 | -17.4 | -4.5 | -7.43 |
Stock-Based Compensation | 16.7 | 100.67 | 43.81 | 37.76 | 30.94 |
Provision & Write-off of Bad Debts | 2.36 | 4.28 | 1.03 | 0.17 | 0.24 |
Other Operating Activities | 98.97 | 69.27 | 40.3 | 46.55 | 102.78 |
Change in Accounts Receivable | -45.19 | -95.85 | 1.16 | -52.18 | 23.1 |
Change in Accounts Payable | -0.85 | -16.79 | -6.41 | -48.04 | 53.39 |
Change in Unearned Revenue | - | - | - | -83.79 | -323.7 |
Change in Other Net Operating Assets | -13.64 | 57.5 | 64.75 | 24.48 | -82.77 |
Operating Cash Flow | 346.47 | 517.86 | 582.06 | 284.83 | 401.23 |
Operating Cash Flow Growth | -33.10% | -11.03% | 104.36% | -29.01% | -60.97% |
Capital Expenditures | -229.23 | -222.18 | -229.2 | -190.37 | -180.54 |
Sale of Property, Plant & Equipment | 23.39 | 4.26 | 0.16 | 8.34 | 26.82 |
Cash Acquisitions | -9.2 | -13.1 | -29.57 | -26.99 | -81.91 |
Investment in Securities | -1.46 | - | -9.87 | -17.32 | -20.97 |
Investing Cash Flow | -216.49 | -231.01 | -268.48 | -226.34 | -256.59 |
Short-Term Debt Issued | - | - | - | - | 42.35 |
Long-Term Debt Issued | 1,391 | 4,322 | 3,029 | 1,146 | 193.01 |
Total Debt Issued | 1,391 | 4,322 | 3,029 | 1,146 | 235.37 |
Short-Term Debt Repaid | -9.05 | -4.47 | -1.69 | -10.39 | - |
Long-Term Debt Repaid | -1,340 | -4,811 | -3,231 | -870.59 | -39.67 |
Total Debt Repaid | -1,349 | -4,815 | -3,233 | -880.99 | -39.67 |
Net Debt Issued (Repaid) | 42.34 | -493.46 | -203.95 | 264.68 | 195.7 |
Issuance of Common Stock | - | 511.2 | - | - | - |
Repurchase of Common Stock | -100.08 | -37.91 | -12.76 | -195.53 | -79.48 |
Common Dividends Paid | -31.44 | -64.62 | -63.9 | -64.59 | -50.6 |
Other Financing Activities | -73.98 | -226.38 | -46.86 | -39.45 | -713.01 |
Financing Cash Flow | -163.15 | -311.17 | -327.48 | -34.89 | -647.39 |
Net Cash Flow | -33.17 | -24.31 | -13.9 | 23.6 | -502.75 |
Free Cash Flow | 117.24 | 295.69 | 352.86 | 94.45 | 220.69 |
Free Cash Flow Growth | -60.35% | -16.20% | 273.58% | -57.20% | -74.97% |
Free Cash Flow Margin | 2.15% | 5.70% | 7.31% | 2.05% | 3.56% |
Free Cash Flow Per Share | 0.96 | 2.37 | 2.87 | 0.76 | 1.69 |
Cash Interest Paid | 120.62 | 256.23 | 272.26 | 183.45 | 132.2 |
Cash Income Tax Paid | 26.02 | 133.19 | 88.51 | 32.29 | 181.18 |
Levered Free Cash Flow | 31.78 | 72.72 | 110.93 | -206.27 | 57.88 |
Unlevered Free Cash Flow | 102.35 | 150.14 | 204.63 | -122.63 | 140.65 |
Change in Working Capital | -59.68 | -55.14 | 59.5 | -159.54 | -329.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.